Jeung Eun Kim

13PUBLICATIONS
120CO-AUTHORS
Molecular targetsSolid tumoursCancer therapy (excl. chemotherapy and radiation therapy)Cancer geneticsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Jan 09, 2026
TAPISTRY: A Phase II Study of Atezolizumab in Patients with Tumor Mutational Burden-High Tumors.

David M Thomas, Jeong Eun Kim, Fabrice Barlesi

|Dec 11, 2025
Gelatin-Based Soft-Tissue Sarcoma Organoids Recapitulate Patient Tumor Characteristics.

Kyuyoung Han, Jiwan Choi, Chae-Eun Kim

|Apr 29, 2025
Correction: Antitumor effects of immunotherapy combined with BRAF and MEK inhibitors in BRAF V600E metastatic colorectal cancer.

Eunyoung Tak, Hye-In An, Amy Sinyoung Lee

|Mar 19, 2025
Antitumor effects of immunotherapy combined with BRAF and MEK inhibitors in BRAF V600E metastatic colorectal cancer.

Eunyoung Tak, Hye-In An, Amy Sinyoung Lee

|Mar 25, 2024
Favorable clinical efficacy of cytotoxic chemotherapy in patients with progressive desmoid tumors: a retrospective real-world study.

Chung Ryul Oh, Hyehyun Jeong, Wanlim Kim

|Mar 08, 2024
Phase I/II Study of Combined BCL-xL and MEK Inhibition with Navitoclax and Trametinib in KRAS or NRAS Mutant Advanced Solid Tumors.

Ryan B Corcoran, Khanh T Do, Jeong E Kim

Pageof 3